Kindly MD, Inc. (NASDAQ: NAKA)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001946573
Market Cap 32.61 Mn
P/B 0.07
P/E -0.36
P/S 16.47
ROIC (Qtr) -4.30
Div Yield % 0.00
Rev 1y % (Qtr) -40.08
Total Debt (Qtr) 203.54 Mn
Debt/Equity (Qtr) 0.43

About

Price action

Investment thesis

Bull case

  • Strong tangible asset base of 689.41M provides 3.39x coverage of total debt 203.54M, indicating robust asset backing and low credit risk.
  • Long-term investments of 661.76M provide solid 1654.53x coverage of long-term debt 399967, indicating strategic financial planning.
  • Tangible assets of 689.41M provide robust 126.06x coverage of other current liabilities 5.47M, indicating strong asset backing.
  • Strong cash position of 24.19M provides 4.42x coverage of other current liabilities 5.47M, indicating excellent liquidity.
  • Strong tangible asset base of 689.41M provides 229.10x coverage of intangibles 3.01M, indicating robust asset quality.

Bear case

  • Operating cash flow of (16.85M) barely covers its investment activities of (686.69M), with a coverage ratio of 0.02, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Investment activities of (686.69M) provide weak support for R&D spending of 377832, which is -1817.45x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Cash reserves of 24.19M provide limited coverage of acquisition spending of (44.82M), which is -0.54x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • The company's operating cash flow of (16.85M) shows concerning coverage of stock compensation expenses of 2.26M, with a -7.45 ratio indicating potential earnings quality issues.
  • Free cash flow of (17.47M) provides weak coverage of capital expenditures of 622722, with a -28.05 ratio suggesting additional external financing needs for growth initiatives.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.04 1.26
EV to Cash from Ops. EV/CFO -1.61 12.78
EV to Debt EV to Debt 0.13 12.10
EV to EBIT EV/EBIT -0.30 10.74
EV to EBITDA EV/EBITDA -1.94 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF -1.55 18.02
EV to Market Cap EV to Market Cap 0.83 432.64
EV to Revenue EV/Rev 13.71 2.77
Price to Book Value [P/B] P/B 0.07 -1.92
Price to Earnings [P/E] P/E -0.36 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) -4,998.95 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -4,585.29 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 563.89 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -3,489.26 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -482.86 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -3,489.26 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -2,976.76 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -98.21 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) -629.56 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -27.50 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.00 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.11 0.39
Current Ratio Curr Ratio (Qtr) 0.13 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.43 -13.19
Interest Cover Ratio Int Coverage (Qtr) -4,998.95 -97.94
Times Interest Earned Times Interest Earned (Qtr) -4,998.95 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) -4,525.00 -95.81
EBIT Margin % EBIT Margin % (Qtr) -4,568.60 -94.97
EBT Margin % EBT Margin % (Qtr) -4,569.52 -105.60
Gross Margin % Gross Margin % (Qtr) 98.80 23.31
Net Profit Margin % Net Margin % (Qtr) -4,569.50 -106.14